Search results
Showing 101 to 150 of 433 results for stroke
This guideline covers the assessment, investigation and management of tinnitus in primary, community and secondary care. It offers advice to healthcare professionals on supporting people presenting with tinnitus and on when to refer for specialist assessment and management.
NG196/7 Question Stroke risk assessment: Can routine data from UK primary care databases clarify stroke risk in people...
treatment after a stroke People could be offered a genetic test in the immediate period after having a stroke to help...
Stable angina: management - To be confirmed Stroke and transient ischaemic attack in over 16s: diagnosis and initial management
The percentage of patients with coronary heart disease, stroke or transient ischemic attack, diabetes and/or chronic obstructive...
In development [GID-TA11352] Expected publication date: 26 February 2025
explain further. The most serious side effects include an increased risk of stroke and an increased risk of death. The diagrams on pages...
Implanting a baroreceptor stimulation device for resistant hypertension
In development [GID-IP1180] Expected publication date: TBC
ischaemic or haemorrhagic stroke: What are the optimal blood pressure targets in adults with prior ischaemic or haemorrhagic...
Ticagrelor for preventing atherothrombotic events after myocardial infarction (TA420)
Evidence-based recommendations on ticagrelor (Brilique) for preventing atherothrombotic events after myocardial infarction in adults.
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes (TA943)
Evidence-based recommendations on hybrid closed loop systems for managing blood glucose levels in type 1 diabetes.
patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD or asthma,...
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
The percentage of patients with coronary heart disease, stroke or TIA, diabetes, hypertension, peripheral arterial disease, heart...
Recommendation ID NG236/3 Question For people after stroke with communication difficulties, what is the optimal tool for assessing...
the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA, diabetes or dementia with a FAST score of 3 or...
Invimestrocel for treating acute ischaemic stroke within 18 to 36 hours of onset TS ID 10190
Awaiting development [GID-TA11283] Expected publication date: TBC
Evidence-based recommendations on rivaroxaban (Xarelto) for preventing atherothrombotic events, such as heart attack and stroke, after acute coronary syndrome in adults.
Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management (NG228)
This guideline covers diagnosing and treating an aneurysmal (caused by a ruptured aneurysm) subarachnoid haemorrhage and its complications. It provides recommendations to improve diagnosis and ensure that the most effective treatments are offered. It includes guidance on follow-up care and information for people (aged 16 and over) who have had an aneurysmal subarachnoid haemorrhage, their families and carers.
Evidence-based recommendations on the CoaguChek XS system for self-monitoring coagulation status in adults and children. The recommendations originally included the InRatio2 PT/INR, but this was withdrawn from the market in October 2016 and is not currently available
Acute upper gastrointestinal bleeding in over 16s: management (CG141)
This guideline covers how upper gastrointestinal bleeding can be effectively managed in adults and young people aged 16 years and older. It aims to identify which diagnostic and therapeutic steps are useful so hospitals can develop a structure in which clinical teams can deliver an optimum service for people who develop this condition.
View recommendations for CG141Show all sections
cognitive and psychological therapy compared to usual care for people after a stroke? Any explanatory notes(if applicable) For a short...
Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism (TA354)
Evidence-based recommendations on edoxaban (Lixiana) for treating deep vein thrombosis and pulmonary embolism in adults and preventing them happening again.
Artificial intelligence for analysing CT brain scans (MIB207)
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence for analysing CT brain scans .
NICE indicators. NM38 smoking cessation guidance.
The percentage of patients with atrial fibrillation in whom stroke risk has been assessed using the CHA2DS2-VASc score risk...
patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma who...
This quality standard covers diagnosing and managing lower limb peripheral arterial disease in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.
View quality statements for QS52Show all sections
Sections for QS52
- Quality statements
- Quality statement 1: Identification and assessment of peripheral arterial disease
- Quality statement 2: Comorbidity assessment
- Quality statement 3: Supervised exercise programmes
- Quality statement 4: Imaging
- Quality statement 5: Angioplasty for intermittent claudication
- About this quality standard
rehabilitation for 7 days a week compared to 5 days a week for people after a stroke? Any explanatory notes(if applicable) For a short...
NICE has developed a medtech innovation briefing (MIB) on ReStore Soft Exo-Suit for gait rehabilitation .
Our board sets out our strategic priorities and policies.
pneumonia after an acute stroke? Any explanatory notes(if applicable) People with dysphagia after an acute stroke are at...
Carotid artery stent placement for symptomatic extracranial carotid stenosis (IPG389)
Evidence-based recommendations on carotid artery stent placement for symptomatic extracranial carotid stenosis. This involves using a metal mesh called a stent to widen the narrowed carotid artery.
View recommendations for IPG389Show all sections
Sections for IPG389
Question For people with different causes of shoulder pain after stroke, what is the clinical and cost effectiveness of interventions...
when these procedures are carried out within 2 weeks of TIA or recovered stroke? Any explanatory notes(if applicable) Carotid stenting...
(non-executive director) Bayer acute stroke trial consultancy. (remunerated – paid to employer)CSL Behring Consultancy advice for...
(non-executive director) Bayer acute stroke trial consultancy. (remunerated – paid to employer)CSL Behring Consultancy advice for...
(non-executive director) Bayer acute stroke trial consultancy. (remunerated – paid to employer)CSL Behring Consultancy advice for...
Find out more about the progress made in implementing NICE guidance on cardiovascular disease prevention
Extracranial to intracranial bypass for intracranial atherosclerosis (IPG596)
Evidence-based recommendations on extracranial to intracranial bypass for intracranial atherosclerosis. This involves joining a blood vessel from outside the skull to one inside the skull to bypass a narrowed or partially blocked vessel.
Pharyngeal electrical stimulation for neurogenic dysphagia (IPG781)
Evidence-based recommendations on pharyngeal electrical stimulation for neurogenic dysphagia. This involves passing a catheter through the nose and into the throat where it is used to deliver small amounts of electrical current. The current travels from the throat to the brain and stimulates the areas involved in swallowing.
View recommendations for IPG781Show all sections
Endovascular stent insertion for intracranial atherosclerotic disease (IPG429)
Evidence-based recommendations on endovascular stent insertion for intracranial atherosclerotic disease. This involves inflating a balloon catheter inserted into an artery in the arm or leg, and positioning a stent in the narrowing to maintain improved blood flow.
View recommendations for IPG429Show all sections
Sections for IPG429
Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes (TA317)
Evidence-based recommendations on prasugrel (Efient) with percutaneous coronary intervention for treating acute coronary syndromes in adults.
NICE indicators. NM39 smoking cessation.
NICE launches second consultation on genetic testing to guide treatment after a stroke
People could be offered a genetic test in the immediate period after having a stroke to help identify the most suitable treatment to reduce their risk of further strokes.
Evidence-based recommendations on thoracoscopic exclusion of the left atrial appendage in atrial fibrillation (with or without other cardiac surgery) for the prevention of thromboembolism. This involves inserting a camera and instruments through small cuts in the chest and closing the left atrial appendage.
View recommendations for IPG400Show all sections
Sections for IPG400
Overprescribing of rivaroxaban in non-atrial fibrillation patients in primary care
are detailed. Patients who were on rivaroxaban for lifelong prevention of stroke and systemic embolism in association with atrial...
domains of language (aphasia) for people with communication difficulties after stroke? Any explanatory notes(if applicable) For a short...
Evidence-based recommendations on percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVI in adults. This involves placing a device inside an artery near the heart.
View recommendations for IPG650Show all sections
Sections for IPG650
under a more unified programme. There was a realisation that AF related stroke was a major problem globally and locally and any measures...